Ivision Tech SpA
MIL:IVN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (4.8), the stock would be worth €2.12 (21% upside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 4 | €1.75 |
0%
|
| 3-Year Average | 4.8 | €2.12 |
+21%
|
| 5-Year Average | 4.8 | €2.12 |
+21%
|
| Industry Average | 12.6 | €5.52 |
+215%
|
| Country Average | 11.1 | €4.87 |
+178%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| IT |
I
|
Ivision Tech SpA
MIL:IVN
|
13.8m EUR | 4 | 1 041.1 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.8B USD | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.7T JPY | 36.2 | 38.6 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.2B CHF | 17.4 | 37.3 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
94.7B DKK | 16.5 | 23.5 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.5B USD | 20.9 | 33 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 15.2 | 32.7 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | 36.2 | -15.5 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
890.2B JPY | 20.8 | 50.3 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
36.7B CNY | 24.7 | 23.3 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8T KRW | -86.3 | -36.2 |
Market Distribution
| Min | 0.7 |
| 30th Percentile | 7 |
| Median | 11.1 |
| 70th Percentile | 14.7 |
| Max | 4 040.2 |
Other Multiples
Ivision Tech SpA
Glance View
Ivision Tech SpA engages in manufacturing eyewear products. The company is headquartered in Martignacco, Udine and currently employs 201 full-time employees. The company went IPO on 2023-08-03. The firm is active in the design and manufacture of acetate eyeglass frames and sunglasses, and combination eyewear (made of two parts in different materials: acetate frontals and metal temples). In addition, the Firm acts as a wholesaler in collaboration with international brands from the luxury sector. iVision Tech operates an integrated production cycle ranging from hand-drawing and/or 3D prototyping to the final stages of assembly and finishing. The firm operates through two divisions. iVision Eyewear segment is active in the design, prototype development, industrialization, and mass production stages of acetate eyewear using specialized machinery and software. iVision R&D business unit is a specific R&D division focused on technological innovations. Moreover, the Firm is engaged in other two activities: the sale of medial masks and of eyeglass machineries.
